Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Response to Neoadjuvant Chemotherapy Combined with Regional Hyperthermia Predicts Long-Term Survival for Adult Patients with Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas.
J. Clin. Oncol. 20, 3156-3164 (2002)
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for local tumor control and overall survival (OS) in adult patients with retroperitoneal or visceral (RP/V) high-risk soft tissue sarcomas (HR-STS).Patients and Methods: From 1991 to 1997, 58 patients with HR-STS at RP/V sites were prospectively treated with four cycles of etoposide, ifosfamide, and doxorubicin combined with RHT followed by surgery, adjuvant chemotherapy, and radiation.
Impact Factor
Scopus SNIP
8.530
0.000
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
PROGNOSTIC FACTORS; PHASE-II; PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; RECURRENT; EXTREMITY; HEAT; TRIAL; MANAGEMENT; RADIATION
Sprache
englisch
Veröffentlichungsjahr
2002
HGF-Berichtsjahr
0
ISSN (print) / ISBN
0732-183X
e-ISSN
1527-7755
Zeitschrift
Journal of Clinical Oncology - JCO
Quellenangaben
Band: 20,
Seiten: 3156-3164
Verlag
American Society of Clinical Oncology
Begutachtungsstatus
Peer reviewed
Institut(e)
CCG Tumor Therapy with Hyperthermia (IMI-KTH)
POF Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er)
Immune Response and Infection
PSP-Element(e)
G-521100-001
Erfassungsdatum
2002-09-09